{{Rsnum
|rsid=654136
|Gene=ME2
|Chromosome=18
|position=50937834
|Orientation=minus
|GMAF=0.4871
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ME2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 17.7 | 52.2 | 30.1
| HCB | 27.0 | 49.6 | 23.4
| JPT | 38.9 | 51.3 | 9.7
| YRI | 48.3 | 45.6 | 6.1
| ASW | 29.8 | 47.4 | 22.8
| CHB | 27.0 | 49.6 | 23.4
| CHD | 22.0 | 54.1 | 23.9
| GIH | 11.0 | 45.0 | 44.0
| LWK | 47.3 | 46.4 | 6.4
| MEX | 13.8 | 41.4 | 44.8
| MKK | 70.5 | 23.1 | 6.4
| TSI | 25.5 | 48.0 | 26.5
| HapMapRevision=28
}}[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1196416] May Underlie Susceptibility to Adolescent-Onset Idiopathic Generalized Epilepsy

{{omim
|id=154270
|desc=MALIC ENZYME 2; ME2
|rsnum=654136
}}

{{omim
|id=154270
|rsnum=654136
|variant=0001
}}

{{PMID Auto
|PMID=15532013
|Title=Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}